The first patients have received BNCT treatment at the HUS Comprehensive Cancer Center in Helsinki, Finland:
https://www.hus.fi/en/newsroom/bnct-treatments-cancer-patients-have-started-part-clinical-trial
The first patients have received BNCT treatment at the HUS Comprehensive Cancer Center in Helsinki, Finland:
https://www.hus.fi/en/newsroom/bnct-treatments-cancer-patients-have-started-part-clinical-trial
Dr. Ataman is specialized in clinical radiation related research with technical and in depth understanding of radiation biology and physics as well as clinical endpoints and passionate on improving oncology outcomes. She will play a central role in the team that plans and executes Tenboron’s clinical program.
Tenboron’s background and BNCT technology are presented in this post: